Radiologic complete response (rCR) in contrast-enhanced magnetic resonance imaging (CE-MRI) after neoadjuvant chemotherapy for early breast cancer predicts recurrence-free survival but not pathologic complete response (pCR).

Simon Peter Gampenrieder; Andreas Peer; Christian Weismann; Matthias Meissnitzer; Gabriel Rinnerthaler; Johanna Webhofer; Theresa Westphal; Marina Riedmann; Thomas Meissnitzer; Heike Egger; Frederike Klaassen Federspiel; Roland Reitsamer; Cornelia Hauser-Kronberger; Katharina Stering; Klaus Hergan; Brigitte Mlineritsch; Richard Greil

doi:10.1186/s13058-018-1091-y

Radiologic complete response (rCR) in contrast-enhanced magnetic resonance imaging (CE-MRI) after neoadjuvant chemotherapy for early breast cancer predicts recurrence-free survival but not pathologic complete response (pCR).

Simon Peter Gampenrieder (First author), Andreas Peer, Christian Weismann (Co-author), Matthias Meissnitzer (Co-author), Gabriel Rinnerthaler (Co-author), Johanna Webhofer, Theresa Westphal (Co-author), Marina Riedmann, Thomas Meissnitzer, Heike Egger, Frederike Klaassen Federspiel (Co-author), Roland Reitsamer (Co-author), Cornelia Hauser-Kronberger, Katharina Stering, Klaus Hergan (Co-author), Brigitte Mlineritsch (Co-author), Richard Greil^* (Last author)

^*Corresponding author for this work

Research output: Contribution to journal › Original Article (Journal) › peer-review

47 Citations (Web of Science)

Original language	English
Pages (from-to)	19
Journal	BREAST CANCER RESEARCH
Volume	21
Issue number	1
DOIs	https://doi.org/10.1186/s13058-018-1091-y
Publication status	Published - 2019

Keywords

DIAGNOSTIC PERFORMANCE
METAANALYSIS

Access to Document

10.1186/s13058-018-1091-y

Cite this

Gampenrieder, S. P., Peer, A., Weismann, C., Meissnitzer, M., Rinnerthaler, G., Webhofer, J., Westphal, T., Riedmann, M., Meissnitzer, T., Egger, H., Klaassen Federspiel, F., Reitsamer, R., Hauser-Kronberger, C., Stering, K., Hergan, K., Mlineritsch, B., & Greil, R. (2019). Radiologic complete response (rCR) in contrast-enhanced magnetic resonance imaging (CE-MRI) after neoadjuvant chemotherapy for early breast cancer predicts recurrence-free survival but not pathologic complete response (pCR). BREAST CANCER RESEARCH , 21(1), 19. https://doi.org/10.1186/s13058-018-1091-y

@article{570b2f8ebb0e4d1b998bf65c37d4bcd1,

title = "Radiologic complete response (rCR) in contrast-enhanced magnetic resonance imaging (CE-MRI) after neoadjuvant chemotherapy for early breast cancer predicts recurrence-free survival but not pathologic complete response (pCR).",

keywords = "DIAGNOSTIC PERFORMANCE, METAANALYSIS",

author = "Gampenrieder, {Simon Peter} and Andreas Peer and Christian Weismann and Matthias Meissnitzer and Gabriel Rinnerthaler and Johanna Webhofer and Theresa Westphal and Marina Riedmann and Thomas Meissnitzer and Heike Egger and {Klaassen Federspiel}, Frederike and Roland Reitsamer and Cornelia Hauser-Kronberger and Katharina Stering and Klaus Hergan and Brigitte Mlineritsch and Richard Greil",

note = "Gampenrieder,; Peer; Rinnerthaler; Weghofer; Westphal; Mlineritsch: Department of Internal Medicine III with Hematology, Medical Oncology, Hemostaseology, Infectiology and Rheumatology, Oncologic Center; Salzburg Cancer Research Institute - Laboratory for Immunological and Molecular Cancer Research (SCRI-LIMCR), Paracelsus Medical University, Salzburg, Austria; Weismann; Meissnitzer,M; Meissnitzer T; Egger; Hergan: Department of Radiology, Paracelsus Medical University Salzburg, Salzburg, Austria.Klaassen-Federspiel; Reitsamer, R: Department of Special Gynecology and Breast Center, Paracelsus Medical University Salzburg, Salzburg, Austria; Hauser-Kronberger: Department of Pathology, Paracelsus Medical University Salzburg, Salzburg, Austria; Greil: Department of Internal Medicine III with Hematology, Medical Oncology, Hemostaseology, Infectiology and Rheumatology, Oncologic Center; Salzburg Cancer Research Institute - Laboratory for Immunological and Molecular Cancer Research (SCRI-LIMCR), Paracelsus Medical University, Salzburg, Austria; Cancer Cluster Salzburg, Salzburg, Austria",

year = "2019",

doi = "10.1186/s13058-018-1091-y",

language = "English",

volume = "21",

pages = "19",

journal = "BREAST CANCER RESEARCH ",

issn = "1465-5411",

publisher = " BioMed Central",

number = "1",

}

Gampenrieder, SP, Peer, A, Weismann, C, Meissnitzer, M , Rinnerthaler, G, Webhofer, J, Westphal, T, Riedmann, M, Meissnitzer, T, Egger, H, Klaassen Federspiel, F , Reitsamer, R, Hauser-Kronberger, C, Stering, K, Hergan, K, Mlineritsch, B & Greil, R 2019, 'Radiologic complete response (rCR) in contrast-enhanced magnetic resonance imaging (CE-MRI) after neoadjuvant chemotherapy for early breast cancer predicts recurrence-free survival but not pathologic complete response (pCR).', BREAST CANCER RESEARCH , vol. 21, no. 1, pp. 19. https://doi.org/10.1186/s13058-018-1091-y

Radiologic complete response (rCR) in contrast-enhanced magnetic resonance imaging (CE-MRI) after neoadjuvant chemotherapy for early breast cancer predicts recurrence-free survival but not pathologic complete response (pCR). / Gampenrieder, Simon Peter (First author); Peer, Andreas; Weismann, Christian (Co-author) et al.
In: BREAST CANCER RESEARCH , Vol. 21, No. 1, 2019, p. 19.

Research output: Contribution to journal › Original Article (Journal) › peer-review

TY - JOUR

T1 - Radiologic complete response (rCR) in contrast-enhanced magnetic resonance imaging (CE-MRI) after neoadjuvant chemotherapy for early breast cancer predicts recurrence-free survival but not pathologic complete response (pCR).

AU - Gampenrieder, Simon Peter

AU - Peer, Andreas

AU - Weismann, Christian

AU - Meissnitzer, Matthias

AU - Rinnerthaler, Gabriel

AU - Webhofer, Johanna

AU - Westphal, Theresa

AU - Riedmann, Marina

AU - Meissnitzer, Thomas

AU - Egger, Heike

AU - Klaassen Federspiel, Frederike

AU - Reitsamer, Roland

AU - Hauser-Kronberger, Cornelia

AU - Stering, Katharina

AU - Hergan, Klaus

AU - Mlineritsch, Brigitte

AU - Greil, Richard

N1 - Gampenrieder,; Peer; Rinnerthaler; Weghofer; Westphal; Mlineritsch: Department of Internal Medicine III with Hematology, Medical Oncology, Hemostaseology, Infectiology and Rheumatology, Oncologic Center; Salzburg Cancer Research Institute - Laboratory for Immunological and Molecular Cancer Research (SCRI-LIMCR), Paracelsus Medical University, Salzburg, Austria; Weismann; Meissnitzer,M; Meissnitzer T; Egger; Hergan: Department of Radiology, Paracelsus Medical University Salzburg, Salzburg, Austria.Klaassen-Federspiel; Reitsamer, R: Department of Special Gynecology and Breast Center, Paracelsus Medical University Salzburg, Salzburg, Austria; Hauser-Kronberger: Department of Pathology, Paracelsus Medical University Salzburg, Salzburg, Austria; Greil: Department of Internal Medicine III with Hematology, Medical Oncology, Hemostaseology, Infectiology and Rheumatology, Oncologic Center; Salzburg Cancer Research Institute - Laboratory for Immunological and Molecular Cancer Research (SCRI-LIMCR), Paracelsus Medical University, Salzburg, Austria; Cancer Cluster Salzburg, Salzburg, Austria

PY - 2019

Y1 - 2019

KW - DIAGNOSTIC PERFORMANCE

KW - METAANALYSIS

U2 - 10.1186/s13058-018-1091-y

DO - 10.1186/s13058-018-1091-y

M3 - Original Article (Journal)

C2 - 30704493

SN - 1465-5411

VL - 21

SP - 19

JO - BREAST CANCER RESEARCH

JF - BREAST CANCER RESEARCH

IS - 1

ER -

Gampenrieder SP, Peer A, Weismann C, Meissnitzer M , Rinnerthaler G, Webhofer J et al. Radiologic complete response (rCR) in contrast-enhanced magnetic resonance imaging (CE-MRI) after neoadjuvant chemotherapy for early breast cancer predicts recurrence-free survival but not pathologic complete response (pCR). BREAST CANCER RESEARCH . 2019;21(1):19. doi: 10.1186/s13058-018-1091-y